Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Q3 2025 Earnings Call Transcript
Operator: Welcome to the Acurx Pharmaceuticals' third quarter 2025 conference call and business update. At this time, all participants are in a listen-only mode.
Acurx Pharmaceuticals Inc. (ACXP)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Sabby Capital Hal Mintz | 8,705 | $37,344 | 0.04% | |
| 2. | Armistice Capital Steven Boyd | 0 | $0 | 0% | |
| 3. | 0 | $0 | 0% | ||
| 4. | 0 | $0 | 0% | ||
| 5. | Sabby Capital Hal Mintz | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.02 | 24,631 | $25,000.47 | 27,708 | 2025-01-06 | Filing | |
| $1.02 | 24,631 | $25,000.47 | 137,183 | 2025-01-06 | Filing | |
| $1.02 | 49,261 | $49,999.92 | 1,097,458 | 2025-01-06 | Filing | |
| $1.02 | 9,852 | $9,999.78 | 22,352 | 2025-01-06 | Filing | |
| $1.02 | 49,261 | $49,999.92 | 1,010,196 | 2025-01-06 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 19,883 | $85,302 | 0.05% | |
| 2. | 16,815 | $72,136 | 0% | |
| 3. | 5,310 | $22,780 | 0% | |
| 4. | 1,500 | $6,435 | 0% | |
| 5. | 67 | $5,286 | 0% |
News See All
Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Q2 2025 Earnings Call Transcript
Operator: Greetings, and welcome to the Acurx Pharmaceuticals to discuss second quarter 2025 Financial results Conference Call.
Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Q1 2025 Earnings Call Transcript
Operator: Greetings and welcome to the Acurx Pharmaceuticals First Quarter 2025 Financial Results and Business Update. At this time, all participants are in a listen-only mode.
Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Q4 2024 Earnings Call Transcript
Operator: Greetings and welcome to the Acurx Pharmaceuticals Fourth Quarter and Full Year 2024 Financial Results and Business Update. At this time, all participants are in a listen-only mode.
Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Q3 2024 Earnings Call Transcript
Operator: Greetings, and welcome to the Acurx Pharmaceuticals, Inc. Third Quarter 2024 Results and Business Update Conference Call.
Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Q2 2024 Earnings Call Transcript
Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Q2 2024 Earnings Call Transcript August 9, 2024Acurx Pharmaceuticals, Inc. misses on earnings expectations.
Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Q1 2024 Earnings Call Transcript
Operator: Hello, and welcome to the Acurx Pharmaceuticals First Quarter 2024 Financial Results Conference Call. [Operator Instructions] As a reminder, this conference is being recorded.
Wall Street Analysts Just Trimmed Price Targets for These 5 Stocks
In this article, we discuss the 5 stocks receiving price-target cut from analysts.
Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Q4 2023 Earnings Call Transcript
Operator: Greetings and welcome to the Acurx Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Earnings Results and Business Update Call.
Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Q3 2023 Earnings Call Transcript
Operator: Ladies and gentlemen, good morning, and welcome to the Acurx Pharmaceuticals Third Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Hedge Fund Resource Center Billionaire Hedge Funds
